- TWD21.24bn
 - TWD19.40bn
 - TWD1.01bn
 
Annual balance sheet for EirGenix, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 937 | 8,290 | 7,127 | 5,553 | 4,598 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 230 | 259 | 298 | 588 | 561 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,494 | 9,070 | 8,288 | 6,916 | 5,952 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,177 | 2,185 | 3,032 | 3,681 | 4,360 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,835 | 11,441 | 11,847 | 11,163 | 10,876 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 642 | 703 | 731 | 707 | 947 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,930 | 1,012 | 1,164 | 1,145 | 1,618 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,906 | 10,429 | 10,683 | 10,017 | 9,258 | 
| Total Liabilities & Shareholders' Equity | 3,835 | 11,441 | 11,847 | 11,163 | 10,876 | 
| Total Common Shares Outstanding |